4//SEC Filing
MUELLER PETER 4
Accession 0001104659-20-065873
CIK 0001720893other
Filed
May 25, 8:00 PM ET
Accepted
May 26, 4:17 PM ET
Size
7.3 KB
Accession
0001104659-20-065873
Insider Transaction Report
Form 4
MUELLER PETER
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-05-21+20,000→ 20,000 totalExercise: $49.74Exp: 2030-05-21→ Common Stock (20,000 underlying) - Award
Stock Option (Right to Buy)
2020-05-21+5,000→ 5,000 totalExercise: $49.74Exp: 2030-05-21→ Common Stock (5,000 underlying)
Footnotes (1)
- [F1]The option will vest in full and become exercisable on the earlier of the first anniversary of the grant date or the day immediately prior to the date of the next BioXcel Therapeutics, Inc. annual meeting of stockholders, subject to the Reporting Person's continued service through such vesting date.
Documents
Issuer
BioXcel Therapeutics, Inc.
CIK 0001720893
Entity typeother
Related Parties
1- filerCIK 0001256126
Filing Metadata
- Form type
- 4
- Filed
- May 25, 8:00 PM ET
- Accepted
- May 26, 4:17 PM ET
- Size
- 7.3 KB